Special research, policies and highlights
The capacity expansion of Beijing stock exchange is accelerated, and the reserve force is sufficient and the strength can be expected
The capacity expansion of the Beijing stock exchange was accelerated and the reserve force was sufficient. Since December 2021, 20 companies have been approved for registration, of which 11 companies have been approved since April 2022. Klaette listed on the Beijing stock exchange on March 21 and Huifeng diamond held the meeting on May 20 took only 80 days and 71 days respectively from the acceptance of application materials to the success of the meeting of the Beijing stock exchange, constantly refreshing the meeting speed record, and the scale of the Beijing stock exchange is accelerating the expansion. From the perspective of reserve forces, as of May 21, 2022, there are still 12 companies accepted by the Beijing stock exchange, 25 companies have inquired, 3 companies listed on the Beijing stock exchange and 1 company submitted to the CSRC, a total of 41 reserve forces.
“Specialized and new” small giant enterprises accelerated their impact on the Beijing stock exchange. Among the 20 registered and approved enterprises and 41 reserve forces, there are 13 state-level “specialized and special new” enterprises, including Kechuang new materials, Hujiang materials, Tede Co., Ltd., Dayu biology, klaette, Rongyi precision, Kaixue cold chain, Zhongcheng technology, consistent konjac, Kerun intelligent control, kungong technology, Qingdao Jicheng and Huifeng diamond.
Market conditions and trading performance
As of May 21, 2022, there were 91 companies listed on the Beijing stock exchange, with 481 million shares traded on the Beijing stock exchange in the first two weeks, a year-on-year increase of 62.55%; The turnover was 5.388 billion yuan, a year-on-year increase of 52.11%; The average transaction price was 11.20 yuan / share, a year-on-year increase of – 6.42%. In the first two weeks, the top 10 in terms of transaction value were senxuan medicine, Bio Valley, Kechuang new material, beiteri, Liancheng CNC, Dayu biology, Jilin Carbon Valley, Changhong energy, Yingtai biology and Qifeng Seiko; The top 10 in the number of transactions are senxuan pharmaceutical, Kechuang Xincai, Bio Valley, Yingtai biology, Dayu biology, China design consulting, Qifeng Seiko, Tonghui information, liujinnian and Tongli shares; The top 10 turnover rates are Kechuang Xincai, Dayu biology, Qifeng Seiko, Bio Valley, Hujiang materials, China design consulting, Tongxin transmission, senxuan medicine, digital man and Dadi electric.
Listing guidance, audit status and IPO performance
In this period (from May 9, 2022 to May 20, 2022, the same below), two new shares were listed on the Beijing stock exchange: 1) Kechuang Xincai (833580. BJ): the company has been focusing on the production and research and development of argon permeable brick at the bottom of ladle for 18 years. It is a national “specialized and special” enterprise. It was listed on the Beijing stock exchange on May 13, 2022, with an issue price of 4.6 yuan / share, an issue price earnings ratio of 15.26 times, and an increase of 141.96% on the first day of listing; 2) Dayu Biology (871970. BJ): the company’s main business is the R & D, production and sales of feed additives (including probiotics and feed enzyme preparations), feed and veterinary drugs. It is a national “specialized and special new” enterprise. It was listed on the Beijing stock exchange on May 18, 2022, with an issue price of 10 yuan / share, an issue P / E ratio of 19.59 times and an increase of 16.70% on the first day of listing.
In this period, 16 companies were added in the IPO counseling stage of Beijing stock exchange. The companies are: Fujian Air China, Zhejiang Huayang, Wuhan Lantian, Guangzhou polymerization, Guangdong liwang, Xiamen Weizheng, Hongyue flowers, Jiangxi Ningxin, Wuhan Songshi, Beijing Xinghao, Tianjin Carl, Gansu Jiugang, Zhejiang feng’an, Shanghai Tieda, Zibo qixingxin and Zhejiang kaihong.
Investor research
In this period (from May 9, 2022 to May 20, 2022, the same below), a total of 46 companies of the Beijing stock exchange accepted the investor survey, among which beiteri, Airong software, Yongshun biology and jingsai technology received a high reception, receiving 13, 10 and 8 institutional investors and individual investors respectively, and 1 for other institutions.
Risk warning: macroeconomic downside risk; Risk of insufficient liquidity; Large fluctuations in performance and the risk of delisting of the company
